In line with our findings, HMGA2 has been reported to be upregulated in oxaliplatin-resistant colorectal cancer, thus further strengthening the findings that HMGA2 functions in the clearance of DNA lesions induced by oxaliplatin (89). Here, HMGA2 is linked to colorectal cancer.